Børsmelding / Presse
Børsmelding / Pressemelding Radiobjelle
March 25, 2003 06:00 ET | Kitron ASA
Arbeidet har en ramme på 5,7 mill, hvorav 1,3 mill til produksjon av en større prøveserie ved Kitrons fabrikk på Røros. Ca 50% av dette totalbeløpet er bevilget av offentlig myndigheter, herunder SND...
nn_logo_cmyk_blue_small.jpg
Generalforsamling i Novo Nordisk A/S
March 25, 2003 06:00 ET | Novo Nordisk A/S
Den ordinære generalforsamling i Novo Nordisk A/S godkendte i dag: Årsrapporten samt meddelte decharge for direktion og bestyrelse. Beslutning om anvendelse af overskud i henhold til det...
nn_logo_cmyk_blue_small.jpg
Annual General Meeting at Novo Nordisk A/S
March 25, 2003 06:00 ET | Novo Nordisk A/S
  The Annual Report and discharged Management and the Board of Directors. The application of profits according to the adopted Annual Report. Thus the dividend will be DKK 3.60 per share of...
logo.gif
PGS TRUST I PREFERRED SECURITIES SYMBOL CHANGE
March 25, 2003 05:52 ET | PGS ASA
PGS' American Depositary Receipts (ADRs) currently trade OTC and are quoted on the Pink Sheets under the ticker symbol "PGOGY." Petroleum Geo-Services will continue the deferral of distribution...
logo.gif
PGS TRUST I PREFERRED SECURITIES SYMBOL CHANGE
March 25, 2003 05:50 ET | PGS ASA
PGS' American Depositary Receipts (ADRs) currently trade OTC and are quoted on the Pink Sheets under the ticker symbol "PGOGY." Petroleum Geo-Services will continue the deferral of distribution...
Biovitrum initiates Phase II Study with its Diabetes Candidate Drug BVT.3498; Primary End-point is Improved Glycaemia Control
March 25, 2003 04:47 ET | Biovitrum AB
STOCKHOLM, Sweden, March 25, 2003 (PRIMEZONE) -- Biovitrum today announced the initiation of a Phase II clinical trial of BVT.3498, its lead compound for type 2 diabetes. Safety, tolerability and...
Riddarhyttan Resources AB: New Drill Holes Completed in the Suurikuusikko Area
March 25, 2003 04:31 ET | Riddarhyttan Resources AB
GOTHENBURG, Sweden, March 25, 2003 (PRIMEZONE) -- Riddarhyttan Resources AB (Other OTC:RRHYF): to clarify the information in the press release from March 24, 2003, we release this restructured...
Nissan North America Signs Deal with Intentia
March 25, 2003 04:22 ET | Intentia
STOCKHOLM, Sweden, March 25, 2003 (PRIMEZONE) -- Leading automotive OEM is seeking higher levels of maintenance efficiency and productivity with less downtime using Movex Plant Maintenance,...
Aker Kværner: Betalingsplan avklart for britisk pensjonskasse
March 25, 2003 04:21 ET | Akastor ASA
"Vi er tilfreds at vi har kommet raskt til enighet med styret i pensjonskassen, og at vi dermed har fjernet usikkerhet med hensyn til våre framtidige årlige innbetalinger. Dette gir oss en...
Biovitrum initiates Phase II Study with its Diabetes Candidate Drug BVT.3498; Primary End-point is Improved Glycaemia Control
March 25, 2003 04:12 ET | Biovitrum AB
STOCKHOLM, Sweden, March 25, 2003 (PRIMEZONE) -- Biovitrum today announced the initiation of a Phase II clinical trial of BVT.3498, its lead compound for type 2 diabetes. Safety, tolerability and...